RAAS Inhibition and Cardiorenal Syndrome

E-ISSN： 1875-6506|10|2|107-111

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.10, Iss.2, 2014-06, pp. : 107-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RAAS inhibition – a practice of medical progress

By Hedner Thomas Kjeldsen Sverre Narkiewicz Krzysztof

Blood Pressure, Vol. 15, Iss. 1, 2006-03 ,pp. : 5-6

Informa Healthcare

Access to resources Recommend Favorite

Arrhythmic complication in cardiorenal syndrome

By Padeletti Luigi

Heart Failure Reviews, Vol. 16, Iss. 6, 2011-11 ,pp. : 569-573

Springer Publishing Company

Access to resources Recommend Favorite

A cardiorenal-pulmonary-cutaneous-muscle syndrome

By Schöpp Sebastian Elitok Saban Bieringer Markus Schneider Wolfgang Luft Friedrich C.

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 199-200

Oxford University Press

Access to resources Recommend Favorite

Epidemiology and outcome of the cardio-renal syndrome

By Cruz Dinna

Heart Failure Reviews, Vol. 16, Iss. 6, 2011-11 ,pp. : 531-542

Springer Publishing Company

Access to resources Recommend Favorite

Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor‐2 With Oxidative Stress Inhibition

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 7, 2015-07 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite